Human schistosomiasis.
Buonfrate D, Ferrari TCA, Adegnika AA, Russell Stothard J, Gobbi FG.
Lancet. 2025 Feb 22;405(10479):658-670. doi: 10.1016/S0140-6736(24)02814-9.
TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature.
Nordmann T, Schlabe S, Feldt T, Gobbi F, Krieg A, Bode JG, Fuchs A, Kraef C, Praktiknjo M, Trebicka J, Ramharter M, Addo MM, Strassburg C, Lohse AW, Luedde T, Schmiedel S, Orth HM.
PLoS Negl Trop Dis. 2021 Dec 21;15(12):e0010065. doi: 10.1371/journal.pntd.0010065. eCollection 2021 Dec.
Portal hypertension in schistosomiasis: pathophysiology and treatment.
Da Silva LC.
Mem Inst Oswaldo Cruz. 1992;87 Suppl 4:183-16. doi: 10.1590/s0074-02761992000800028.
Noncirrhotic portal hypertension.
Hillaire S, Valla D, Lebrec D.
Clin Liver Dis. 1997 May;1(1):223-40, xiii. doi: 10.1016/s1089-3261(05)70265-8.
Hepatosplenic schistosomiasis: a model for the study of portal hypertension.
Strauss E.
Ann Hepatol. 2002 Jan-Mar;1(1):6-11.
[Surgical treatment of portal hypertension in schistosomiasis mansoni].
Petroianu A.
Rev Soc Bras Med Trop. 2003 Mar-Apr;36(2):253-65. doi: 10.1590/s0037-86822003000200010. Epub 2003 Jun 10.
Efficacy and safety of transjugular intrahepatic portosystemic shunt for the treatment of schistosomiasis-induced portal hypertension: a retrospective case series.
Huang S, Liu J, Yao J, Zhao J, Wang Y, Ju S, Wang C, Yang C, Bai Y, Xiong B.
Eur J Gastroenterol Hepatol. 2022 Oct 1;34(10):1090-1097. doi: 10.1097/MEG.0000000000002433. Epub 2022 Aug 24.
[Portal hypertension and schistosomiasis: "an originally killing entity"].
Klotz F.
Bull Soc Pathol Exot. 2003 Aug;96(3):191-5.
Hemodynamic studies of portal hypertension in schistosomiasis.
Coutinho A.
Am J Med. 1968 Apr;44(4):547-56. doi: 10.1016/0002-9343(68)90055-7.
[PORTAL HYPERTENSION].
CHIANDUSSI L, GRECO F.
Omnia Med Ther. 1963 Jan-Jun;41:1-81.
